Navigation Links
First-ever 'State of the Carbon Cycle Report' finds troubling imbalance
Date:11/14/2007

The first State of the Carbon Cycle Report for North America, released online this week by the U.S. Climate Change Science Program, finds the continents carbon budget increasingly overwhelmed by human-caused emissions. North American sources release nearly 2 billion tons of carbon into the atmosphere each year, mostly as carbon dioxide. Carbon sinks such as growing forests may remove up to half this amount, but these current sinks may turn into new sources as climate changes.

By burning fossil fuel and clearing forests human beings have significantly altered the global carbon cycle, says Chris Field of the Carnegie Institutions Department of Global Ecology, one of the reports lead authors. A result has been the buildup of carbon dioxide in the atmosphere, but so far this has been partially offset by carbon uptake by the oceans and by plants and soils on land.

In effect, we have been getting a huge subsidy from these unmanaged parts of the carbon cycle, notes Field. Overall, this subsidy has sequestered, or hidden from the atmosphere, approximately 200 billion tons of carbon. In North America much of it has come from the regrowth of forests on former farmland and the uptake of carbon by agricultural soils.

But these carbon sinks may be reaching their limit as forests mature and climate conditions change. And some may literally go up in smoke if wildfires become more frequent, as some climate simulations predict. Planting forests and adopting carbon-conserving practices such as no-till agriculture may increase carbon sinks somewhat, but this would not come close to compensating for carbon emissions, which continue to accelerate.

There are a lot of good reasons for replenishing our forests and encouraging better agricultural practices, says Ken Caldeira, another author of the report, also at Carnegies Department of Global Ecology. But if we want to mitigate our impact on the carbon cycle, theres no escaping the fact tha
'/>"/>

Contact: Chris Field
cfield@globalecology.stanford.edu
650-462-1047 x201
Carnegie Institution
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. First-ever study: lack of critical lubricant causes wear in joints
2. Obesity and the central nervous system -- the state of the art
3. University of Minnesota study refutes belief that black men have more aggressive prostate cancer
4. Iowa State University conference examines developing bioeconomy
5. University and state agencies to forecast local health effects of climate change
6. K-State Veterinary Lab routinely tests for bluetongue virus
7. New prostate cancer research findings
8. Iowa State professors genome research published in the latest issue of Science
9. Leading researchers to reveal comprehensive dos and donts for prostate cancer
10. K-State chemistry professor to receive Masao Horiba award
11. K-State sociologists use Department of Energy grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... (May 18, 2013) The AGA Research Foundation announced ... the relationship between the gut microbiota, one of today,s ... disease. , The AGA Research Awards Panel selected ... Massachusetts General Hospital and Harvard Medical School, Boston, as ... Dr. Chan will receive $25,000 of funding, commencing in ...
(Date:5/17/2013)... the interaction of a group of proteins in the ... identified a new target that could increase cell survival. ... School of Biochemistry and published in the EMBO ... eventually lead to new therapies for stroke and other ... by the team which identified a protein, known as ...
(Date:5/17/2013)... Bethesda, MD The Federation of American Societies for ... of National Institutes of Health (NIH) funding trends highlighting ... to support critical research. The FASEB analysis follows a ... Francis Collins, MD, PhD, who testified that the $1.6 ... to sequestration is "having a substantial impact on the ...
Breaking Biology News(10 mins):New gut microbiome research to explore red meat -- colorectal cancer pathway 2SUMO wrestling cells reveal new protective mechanism target for stroke 2
... 10, 2009)Attempts to treat critical limb ischemia in ... are still thwarted by restenosis (the re-narrowing of ... stenting), the need for repeat treatments and the ... death (gangrene) and amputation. Interventional radiologists have been ...
... Detects Faces in Motion, Matches with Watch-list ... Lithuania, March 9 Neurotechnology, a provider ... the availability of VeriLook Surveillance SDK, a ... using live video streams from high-resolution digital ...
... be tough, but scientists have found a Yellowstone National ... simple one-celled algae called Cyanidioschyzon -- thrives ... occurs naturally around hot springs, said Tim McDermott, professor ... at Montana State University. Cyanidioschyzon could ...
Cached Biology News:Promising 3-year data: Saving limbs with drug-eluting stents 2Promising 3-year data: Saving limbs with drug-eluting stents 3VeriLook Surveillance SDK Provides Real-Time Face Identification Using Video Surveillance Cameras 2VeriLook Surveillance SDK Provides Real-Time Face Identification Using Video Surveillance Cameras 3Montana State team finds Yellowstone alga that detoxifies arsenic 2Montana State team finds Yellowstone alga that detoxifies arsenic 3
(Date:5/21/2013)... Branchburg, NJ (PRWEB) May 21, 2013 ... enhancement industry, has appointed Dale Braddy to Southeastern USA ... proactively bolster its sales muscle in the Southeast. ... a food ingredient brokerage and supplier to food processors ... past 13 years in the food industry and has ...
(Date:5/21/2013)... As the R&D sector becomes ... the industry to deliver better products, faster. Collaborations ... companies often means turning big ideas into reality, ... collaboration with Sensidose AB and Recipharm, is one ... to market sooner. The partnership resulted in the ...
(Date:5/21/2013)... May 21, 2013  Synthetic Biologics, Inc. (NYSE MKT: SYN), ... of serious infectious diseases, announced today that Jeffrey ... Annual Marcum LLP MicroCap Conference on Thursday, May 30, ... the Grand Hyatt Hotel. Mr. Riley is scheduled to present ... of Synthetic Biologics, presentation can be accessed by logging onto ...
(Date:5/21/2013)... NANONEX CORPORATION, a pioneer and leading company ... successful delivery and installation of a new nanoimprint ... major Japanese manufacturing company. , ... lithography tool that has the ability to process ... types. Based on Nanonex inventions and proprietary technologies, ...
Breaking Biology Technology:The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference 2Nanonex Announces the Shipment and Installation of an Innovative Nanoimprint Lithography System for Fully Automated Manufacturing 2
... BOULDER, Colo., and IPSWICH, Mass., July 27, ... Biolabs, Inc. (NEB) announce today that they ... whereby SomaLogic will provide specific SOMAmers as ... and future NEB nucleic acid amplification and ...
... July 27, 2011 Cadence Pharmaceuticals, Inc. (NASDAQ: ... and commercializing proprietary products principally for use in the hospital ... ended June 30, 2011 financial results on Wednesday, August 3, ... call and live webcast to discuss the financial results on ...
... Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) today ... registration trial of KRX-0401 (perifosine) for the treatment of ... over 430 randomized patients, is being conducted pursuant to ... Drug Administration (FDA) and with Fast-Track Designation.  Perifosine is ...
Cached Biology Technology:Agreement Between SomaLogic and New England Biolabs Enables the Use of SOMAmer Technology for the Optimization of Multiple PCR Products 2Keryx Biopharmaceuticals Announces Completion of Patient Enrollment in KRX-0401 (Perifosine) Phase 3 Refractory Advanced Colorectal Cancer Study 2Keryx Biopharmaceuticals Announces Completion of Patient Enrollment in KRX-0401 (Perifosine) Phase 3 Refractory Advanced Colorectal Cancer Study 3Keryx Biopharmaceuticals Announces Completion of Patient Enrollment in KRX-0401 (Perifosine) Phase 3 Refractory Advanced Colorectal Cancer Study 4Keryx Biopharmaceuticals Announces Completion of Patient Enrollment in KRX-0401 (Perifosine) Phase 3 Refractory Advanced Colorectal Cancer Study 5